ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Premium Icon프리미엄 Help Menu
S&P 500
5,982.72
-0.84%
US Tech 100
21,112.40
-1.21%
다우존스 지수
42,215.80
-0.70%
Bitcoin
105,530.74
0.89%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Biodesix Inc (BDSX) 시세

Biodesix Inc

Biodesix Inc (BDSX)

NASDAQ
0.2845
-0.0033
(-1.15%)
마감 18 6월 5:00AM
15분 지연 - 실시간으로 업그레이드
0.2849
0.0004
(0.14%)
시간외 거래: 8:56AM
15분 지연 - 실시간으로 업그레이드

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
0.2849
매수가
0.275
매도가
0.28
거래량
1,258,914
0.2726 일간 변동폭 0.295
0.1718 52주 범위 2.04
market_cap
41.756M
전일 종가
0.2878
개장가
0.2899
최근 거래 시간
270
@
0.2849
(formt)
마지막 거래 시간
재정 규모
US$ 353,311
VWAP
0.280647
평균 볼륨(3m)
8,983,127
발행 주식
146,563,031
배당수익률
-
주가수익률
-0.99
주당순이익(EPS)
-0.29
매출
71.32M
순이익
-42.93M

Biodesix Inc 정보

Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic researc... Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics. 더 보기

섹터
Medical Laboratories
산업
Medical Laboratories
웹사이트
www.biodesix.com
본부
Wilmington, Delaware, USA
설립됨
-
Biodesix Inc is listed in the Medical Laboratories sector of the 나스닥 with ticker BDSX. The last closing price for Biodesix was US$0.29. Over the last year, Biodesix shares have traded in a share price range of US$ 0.1718 to US$ 2.04.

Biodesix currently has 146,563,031 shares in issue. The market capitalisation of Biodesix is US$42.18 million. Biodesix has a price to earnings ratio (PE ratio) of -0.99.

BDSX 최신 뉴스

추가 뉴스

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
31 5월 2025
BDSX (-1.15%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
14 5월 2025
BDSX (-1.15%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
14 5월 2025
BDSX (-1.15%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
14 5월 2025
BDSX (-1.15%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
14 5월 2025
BDSX (-1.15%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.009053.280768533620.275850.330.274331992350.32173846CS
4-0.0019-0.6624825662480.28680.51470.2541231720280.37836454CS
12-0.5351-65.2560975610.820.850.171889831270.36837036CS
26-1.0851-79.2043795621.371.610.171845547970.39712949CS
52-1.3351-82.41358024691.622.040.171823943810.46061849CS
156-1.2151-81.00666666671.530.17188794890.57133971CS
260-13.3051-97.903605592313.5931.990.17186418381.3569422CS

BDSX - Frequently Asked Questions (FAQ)

What is the current Biodesix share price?
The current share price of Biodesix is US$ 0.2849
How many Biodesix shares are in issue?
Biodesix has 146,563,031 shares in issue
What is the market cap of Biodesix?
The market capitalisation of Biodesix is USD 42.18M
What is the 1 year trading range for Biodesix share price?
Biodesix has traded in the range of US$ 0.1718 to US$ 2.04 during the past year
What is the PE ratio of Biodesix?
The price to earnings ratio of Biodesix is -0.99
What is the cash to sales ratio of Biodesix?
The cash to sales ratio of Biodesix is 0.6
What is the reporting currency for Biodesix?
Biodesix reports financial results in USD
What is the latest annual turnover for Biodesix?
The latest annual turnover of Biodesix is USD 71.32M
What is the latest annual profit for Biodesix?
The latest annual profit of Biodesix is USD -42.93M
What is the registered address of Biodesix?
The registered address for Biodesix is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Biodesix website address?
The website address for Biodesix is www.biodesix.com
Which industry sector does Biodesix operate in?
Biodesix operates in the MEDICAL LABORATORIES sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
CEROCERo Therapeutics Holdings Inc
US$ 19.92
(190.04%)
57.35M
ACXPAcurx Pharmaceuticals Inc
US$ 0.8149
(165.35%)
337.45M
EYENEyenovia Inc
US$ 6.96
(134.34%)
29.94M
RBNERobin Energy Ltd
US$ 10.60
(92.03%)
45.44M
RELIReliance Global Group Inc
US$ 2.20
(86.44%)
19.29M
SDSTStardust Power Inc
US$ 0.186
(-52.10%)
39.42M
SHOTWSafety Shot Inc
US$ 0.0161
(-45.97%)
12.35k
RUNSunrun Inc
US$ 5.78
(-40.04%)
120.05M
SEDGSolarEdge Technologies Inc
US$ 15.94
(-33.53%)
33.14M
GOVXGeoVax Labs Inc
US$ 0.8924
(-32.39%)
2.64M
PCSAProcessa Pharmaceuticals Inc
US$ 0.2632
(16.93%)
575.5M
GNLNGreenlane Holdings Inc
US$ 0.0104
(-16.13%)
392.94M
HCTIHealthcare Triangle Inc
US$ 0.022
(-16.67%)
356.57M
ACXPAcurx Pharmaceuticals Inc
US$ 0.8149
(165.35%)
337.45M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 11.9373
(-7.75%)
143.55M

BDSX Discussion

게시물 보기
Scotty9 Scotty9 4 주 전
Any news on the r/s voters passed it may 20th 1 to 2 or 20
👍️0
Chrion Capital Chrion Capital 4 주 전
+>>>BDSX - New Highs Printing for the day! Should continue into tomorrow. Insiders buying knows somethings coming.

Happy Trading

CC
👍️0
subslover subslover 4 주 전
Yes! I'm with you on that, good buddy!♥️
👍 1
ollik78 ollik78 4 주 전
Looking for the $ coming months 
👍️0
glenn1919 glenn1919 4 주 전
BDSX......................................................................a/h
👍️0
Scotty9 Scotty9 4 주 전
Thanks good to know
👍️0
subslover subslover 4 주 전
Heavy insider buying https://www.otcmarkets.com/filing/html?id=18485455&guid=Emc-kpRtlDqmB3h
👍️0
glenn1919 glenn1919 1 월 전
BDSX.............................................................a/h
👍️0
georgie18 georgie18 3 월 전
BDSX...96...🥳

georgie18

Member Level
Re: georgie18 post# 18

Wednesday, March 05, 2025 12:01:26 PM

Post#
20
of 20
BDSX...92s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 670653

Wednesday, March 05, 2025 11:03:48 AM

Post#
676211
of 676223
BDSX....82...Off the .65 Bottom...🥳...Added this bottom...https://schrts.co/HFpbquXc

georgie18

Member Level
Re: None

Tuesday, January 07, 2025 7:47:47 AM

Post#
670653
of 676211
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html
👍️0
georgie18 georgie18 3 월 전
BDSX...92s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 670653

Wednesday, March 05, 2025 11:03:48 AM

Post#
676211
of 676223
BDSX....82...Off the .65 Bottom...🥳...Added this bottom...https://schrts.co/HFpbquXc

georgie18

Member Level
Re: None

Tuesday, January 07, 2025 7:47:47 AM

Post#
670653
of 676211
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html
👍️0
TrendTrade2016 TrendTrade2016 3 월 전
BDSX....SLOW GRIND TO A DOLLA
👍️0
georgie18 georgie18 3 월 전
BDSX....82...Off the .65 Bottom...🥳...Added this bottom...https://schrts.co/HFpbquXc

georgie18

Member Level
Re: None

Tuesday, January 07, 2025 7:47:47 AM

Post#
670653
of 676211
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html
👍️0
TrendTrade2016 TrendTrade2016 3 월 전
BDSX BOTTOM BUSTER
👍️0
georgie18 georgie18 5 월 전
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html
👍️0
PonkenPlonken PonkenPlonken 6 월 전
Mr Schuler is buying shares again
👍️0
tw0122 tw0122 7 월 전
Is selling $250 million in stock fro time to time on the downside.. Separately, Biodesix filed a registration statement to sell up to $250 million in securities from time to time.
👍️0
tw0122 tw0122 7 월 전
Lung diagnostics cancer revenues improving still has $33m cash $1.49 +'14%
👍️0
AJ Freely AJ Freely 2 년 전
$BDSX - Up 12%/ Current Price $1.34.
Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules
👍️0
1hot toddy 1hot toddy 3 년 전
WOOOOOOW 130K SHARES BUY NOW 2.6 MIL SHARE BUY $

3 MILLION $ BUY $$$$$$$$$$$$$$$$$$$$$$
👍️0
Leg58 Leg58 3 년 전
Lots if potential but will public offering dilute price?
👍️0
Leg58 Leg58 3 년 전
Lots if potential but will public offering dilute price?
👍️0
subslover subslover 3 년 전
Earnings look good.
👍️0
subslover subslover 3 년 전
Earnings look good.
👍️0
MiamiGent MiamiGent 3 년 전
BDSX Has news this morning!

The contract covers the company’s entire lung diagnostic portfolio: Nodify XL2®, Nodify CDT®, VeriStrat®, GeneStrat® ddPCR, and GeneStrat NGS™ testing.

https://investors.biodesix.com/news-releases/news-release-details/biodesix-awarded-us-federal-supply-schedule-contract-its

https://stockcharts.com/h-sc/ui?s=BDSX
👍️0
carusso carusso 3 년 전
Not so much...
👍️0
crudeoil24 crudeoil24 3 년 전
LET'S GO BDSX !!!!!
👍️0
crudeoil24 crudeoil24 3 년 전
Biodesix to Participate in Two Upcoming Investor Conferences in September
6:00 am ET September 6, 2022 (BusinessWire) Print
Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will participate in two upcoming investor conferences:

Morgan Stanley 20th Annual Global Healthcare Conference Date: Tuesday, September 13, 2022 at 9:10 a.m. ET Format: Fireside Chat and 1x1 meetings Location: Sheraton Hotel, New York, NY Details: The fireside chat will be webcast live and available for replay under "News & Events" in the Investors section of the Company's website at www.biodesix.com.

H.C. Wainwright 24th Annual Global Investment Conference Dates: September 12-14, 2022 Format: 1x1 meetings Location: Lotte New York Palace Hotel, New York, NY
👍️0
crudeoil24 crudeoil24 3 년 전
Biodesix, Inc. is a United States-based company engaged in developing and commercializing blood-based diagnostic tests for oncology. The Company’s product Biodesix Lung Reflex integrates genomic and proteomic blood-based results to reveal both sides of lung cancer. Its GeneStrat test offers blood-based mutation results within 72 hours for patients with non-small cell lung cancer (NSCLC). Its VeriStrat testing provides blood-based predictive and prognostic proteomic information with (NSCLC) who test negative for estimated glomerular filtration rate (EGFR) mutations (EGFR wild-type) or whose EGFR mutation status is unknown.
👍️0
Leg58 Leg58 3 년 전
US based company is quietly trending up. IMHO.
GLTA
👍️0

최근 히스토리

NASDAQ
BDSX
Biodesix
Delayed Upgrade Clock
ADVFN Logo
대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN Ltd - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지